| Leeanna Miller, PHARMD | |
|
210 Black Gold Blvd Ste 104, Hazard, KY 41701-2620 | |
| (606) 487-7380 | |
| Not Available |
| Full Name | Leeanna Miller |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 210 Black Gold Blvd Ste 104, Hazard, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225725575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 20175 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Leeanna Miller, PHARMD Po Box 719, Bonnyman, KY 41719-0719 Ph: (606) 438-3722 | Leeanna Miller, PHARMD 210 Black Gold Blvd Ste 104, Hazard, KY 41701-2620 Ph: (606) 487-7380 |
News Archive
The U.S. Food and Drug Administration today approved Mirena (levonorgestrel intrauterine system) to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention. This is the first intrauterine device approved by the FDA for this additional indication.
A study by researchers at Mayo Clinic's campus in Jacksonville, Florida has found that barriers to patients receiving stem cell therapy as part of their treatment for multiple myeloma include income, education, insurance status and access to care at an academic center or facility that treats a high volume of patients.
In this unique volume, leading international experts share their experiences in the management of head and neck tumors, providing a guidebook for all surgeons dealing with head and neck neoplasms.
A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or 'bird flu', even when given late in the course of illness.
Forest Laboratories announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds additional rights to the combination of ceftazidime and NXL 104, through a transaction with AstraZeneca executed immediately following AstraZeneca's announced acquisition of Novexel, S.A.
› Verified 7 days ago
Dr. Jeffrey Ryan Meadows, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6600 | |
Sydney Nicole Smith, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 181 Village Ln Ste 2, Hazard, KY 41701 Phone: 844-858-5955 | |
Jerry Wayne Mullins, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1587 Combs Rd., Suite 2, Hazard, KY 41701 Phone: 606-910-0555 Fax: 606-910-0124 | |
Mrs. Krystal Dawn Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 241 Elk Run, Hazard, KY 41701 Phone: 606-497-5942 | |
Dr. Christopher Case, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-1331 Fax: 606-487-6008 | |
Brian Scott Hancock, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Medical Center Dr, Hazard, KY 41701 Phone: 606-439-6600 |